(Press-News.org) New research from Intermountain Health in Salt Lake City finds that genetic screening is effective in identifying patients who have a heart condition known as cardiomyopathy to improve their quality of life and reduce deaths.
By undergoing genetic screening to identity those with the potentially-fatal heart condition, clinicians can more closely monitor them and use medical interventions, when necessary, that could improve the quality of these patients’ lives, and potentially save them, researchers say in a new study of more than 30,000 heart patients.
“Our findings show that we’re missing a large percentage of the population that’s walking around with a genetic predisposition to a devastating kind of heart disease,” said Kirk Knowlton, MD, lead author of the study and director of cardiovascular research at Intermountain Medical Center. “Widespread genetic testing can identify these patients, and their families, which means we can better treat them.”
In its different forms, cardiomyopathy – which affects the heart’s ability to pump blood – can stiffen the muscles of the heart, enlarge them, and/or weaken them, which can lead to irregular heartbeat, heart attack, and even death. Some types of cardiomyopathy are acquired, and caused by another disease condition like muscular dystrophy or alcoholism; and about half of cases are genetically inherited.
Findings from the Intermountain study were presented at the American Heart Association’s Scientific Sessions 2023 national conference in Philadelphia on Nov. 12, 2023.
This study is part of the HerediGene: Population Study, the world’s largest DNA mapping initiative, which is a partnership between Intermountain Health and Icelandic company deCODE.
The goal of the project is to discover new connections between genetics and human disease. When appropriate, it’s also providing genetic screenings for participants so they know about their risks of disease development, and what actions they can take to protect their health.
Inherited cardiomyopathy is one of the diseases tested for, via identification the pathogenic TTN variant, which affects the gene that creates a protein in cardiac muscle.
In the study, Intermountain researchers looked at the first 32,159 sequenced patients, and found 411 with a pathogenic/likely pathogenic TNN variant. Of those, 135 (32.8%) had a cardiomyopathy diagnosis, and 276 (67.2%) did not.
In total, researchers found that about one third of patients with potential pathogenic TNN variant had a cardiomyopathy diagnosis; and 27% did not but had an indication of it.
They also found that demographic and clinical characters were significantly different among those without and without a cardiomyopathy diagnosis. In those without, 75 (27%) had one or more clinical indications of cardiomyopathy. Of those with an indication of cardiomyopathy but without a diagnosis, 12 (16%) had died, and 22 (23%) had been hospitalized for heart failure.
These findings stress the importance of more accessible whole genome testing, say Intermountain researchers.
“If we know someone has this genetic variant, we can make a difference for that person and their families.,” said Dr. Knowlton. “But we won’t know who should receive this kind of monitoring if we don’t know who they are,” he added. “Genetic testing can help us with that.”
By undergoing testing and identification, those who have the genetic variant would then be monitored more carefully with regular echocardiograms, at younger ages, and as soon as they start showing signs of the disease, and receive the standard of cardiomyopathy of care, researchers say.
###
END
SAN DIEGO, CA, NOVEMBER 12, 2023 — A recent study from Hospital for Special Surgery (HSS) and others has found a correlation between obesity and more severe disease flare symptoms that negatively affect quality of life in patients with early rheumatoid arthritis (RA), a systemic, autoimmune, inflammatory disorder affecting multiple joints in the body. The study will be presented at ACR Convergence 2023, the annual meeting of the American College of Rheumatology.
RA is usually treated with a combination of medications to relieve swelling and pain while regulating the immune ...
About The Study: Self-monitoring and physician-guided titration of antihypertensive medications was associated with lower blood pressure during the first nine months postpartum than usual postnatal outpatient care in this randomized clinical trial involving 220 participants in the United Kingdom.
Authors: Paul Leeson, Ph.D., of the University of Oxford in Oxford, United Kingdom, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2023.21523)
Editor’s ...
· High blood pressure is the leading cause of morbidity and mortality
· Losing one teaspoon of salt a day results in systolic blood pressure decline comparable to effect achieved with drugs
· First study to show people already on blood pressure medication could further lower their blood pressure by reducing sodium
Chicago --- Nearly everyone can lower their blood pressure, even people currently on blood pressure-reducing drugs, by lowering their sodium intake, reports a new study from Northwestern Medicine, Vanderbilt University Medical Center and the University of Alabama at Birmingham.
“In the study, ...
About The Study: Dietary sodium reduction significantly lowered blood pressure in the majority of middle-aged to elderly adults in this study including 213 participants. The decline in blood pressure from a high- to low-sodium diet was independent of hypertension status and antihypertensive medication use, was generally consistent across subgroups, and did not result in excess adverse events.
Authors: Deepak K. Gupta, M.D., M.S.C.I., of the Vanderbilt University Medical Center in Nashville, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2023.23651)
Editor’s ...
About The Study: This randomized clinical trial found that in patients with advanced heart failure treated with a fully magnetically levitated left ventricular assist device, avoidance of aspirin as part of an antithrombotic regimen, which includes a vitamin K antagonist, is not inferior to a regimen containing aspirin, does not increase thromboembolism risk, and is associated with a reduction in bleeding events.
Authors: Mandeep R. Mehra, M.D., M.Sc., of Brigham and Women’s Hospital and Harvard Medical School in Boston, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link ...
According to the American Medical Association, approximately 25% of all patients used telehealth services during the last year, exceeding the 5% who accessed their care this way before the pandemic.[1] The American Heart Association (AHA) Center for Telehealth, unveiled today, recognizes the critical role telehealth can play as a solution to close gaps in health care access, particularly in rural and underserved areas, and deliver quality care to populations that have little to no access to traditional ...
While high cholesterol, high blood pressure, diabetes and smoking are well known heart disease risks, not everyone who has a heart attack has them. In fact, previous research has shown that 14% to 27% of heart attack patients have none of these risk factors.
Now, a new study from researchers at Intermountain Health in Salt Lake City finds that these patients had one thing in common: they all tended to have high levels of coronary calcium.
Results of the new Intermountain study show that scans that detect this kind of plaque buildup should be considered as ...
WASHINGTON — Advanced brain imaging techniques reveal how adolescent brain development influences, and is influenced by, factors including chronic stress and mood disorders. The findings will be presented on Monday, November 13, 11:15 a.m. – 12:15 p.m. EST at Neuroscience 2023, the annual meeting of the Society for Neuroscience and the world’s largest source of emerging news about brain science and health.
Adolescence is a time of social, biological, and emotional changes, as well as continued brain development. Mental health among teenagers was already declining before the COVID-19 pandemic, according to data from the Centers for Disease Control ...
WASHINGTON — Changes in a person’s environment can have long-term, significant effects on the brain, whether it’s the inhalation of wildfire smoke or the experience of childhood trauma. The findings will be presented on Tuesday, November 14, 11:15 a.m. – 12:15 p.m. at Neuroscience 2023, the annual meeting of the Society for Neuroscience and the world’s largest source of emerging news about brain science and health.
The environment plays an important role in a person’s brain health and cognitive function. Previous research has established that both one’s physical and social environment effect the brain and nervous system. Next, researchers ...
WASHINGTON — Using machine learning, researchers are able to use data from the brain to glean deeper insights and apply this new knowledge in clinical settings. The findings will be presented on Monday, November 13, 2–3 p.m. EST at Neuroscience 2023, the annual meeting of the Society for Neuroscience and the world’s largest source of emerging news about brain science and health.
Machine learning is a branch of artificial intelligence (AI) that centers on enabling computers to analyze data in increasingly complex ...
